GSK to advance Voltarol’s market dominance in UK
This article is powered by OTC Bulletin & The Rose Sheet
Executive Summary
GlaxoSmithKline (GSK) Consumer Healthcare is set to spend big on marketing and innovation to enable its Voltarol brand to capture a 50% share of the UK’s OTC topical analgesic market.